BGI Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	2,954	3,286	3,935	4,732	5,160	6,590
Short-Term Investments	-	-	-	23.28	11.2	6.57
Trading Asset Securities	411.01	492.42	375.12	753.58	1,232	2,049
Cash & Short-Term Investments	3,365	3,778	4,310	5,509	6,403	8,646
Cash Growth	-22.00%	-12.34%	-21.77%	-13.96%	-25.94%	59.22%
Accounts Receivable	1,725	1,665	1,679	1,464	2,223	1,244
Other Receivables	78.08	75.77	73.24	54.22	174.47	49.74
Receivables	1,803	1,741	1,752	1,518	2,397	1,294
Inventory	465.85	480.2	601.62	602.18	717.83	877.72
Other Current Assets	179.6	150.91	212.07	303.49	257.24	217.2
Total Current Assets	5,813	6,150	6,876	7,933	9,775	11,035
Property, Plant & Equipment	2,737	2,766	2,854	3,190	2,191	1,400
Long-Term Investments	641.1	1,436	1,306	1,252	1,328	898.21
Goodwill	36.47	36.47	36.47	47.11	47.11	47.11
Other Intangible Assets	412.56	406.53	359.6	418.82	410.89	245.46
Long-Term Deferred Tax Assets	242.67	236.02	230.47	241.58	236.29	200.29
Long-Term Deferred Charges	125.68	157.38	299.14	362.86	209.51	177.65
Other Long-Term Assets	1,337	561.2	580.15	167.17	187.25	250.86
Total Assets	11,345	11,749	12,542	13,613	14,385	14,254
Accounts Payable	693.37	847.12	1,137	864.6	1,025	805.32
Accrued Expenses	121.94	813.66	799.98	668.29	958.97	653.08
Short-Term Debt	-	-	24.91	-	-	5.01
Current Portion of Long-Term Debt	122.21	88.9	31.23	24.18	-	35.74
Current Portion of Leases	-	31.67	26.32	57.79	63.33	90.6
Current Income Taxes Payable	25.05	7.6	12.7	59.79	77.35	167.83
Current Unearned Revenue	580.22	619.84	637.83	699.71	929.35	1,410
Other Current Liabilities	696.25	128.13	172.17	922.68	901.93	216.41
Total Current Liabilities	2,239	2,537	2,842	3,297	3,956	3,384
Long-Term Debt	416.77	442.82	339.11	215.68	-	631.96
Long-Term Leases	64.5	73.47	49.7	67.75	136.68	84.44
Long-Term Unearned Revenue	69.07	70.45	15.11	15.39	19.68	36.07
Long-Term Deferred Tax Liabilities	15.22	16.42	24.89	13.13	51.56	5.19
Other Long-Term Liabilities	1.46	1.45	-	-	-	671.57
Total Liabilities	2,806	3,142	3,271	3,609	4,164	4,813
Common Stock	418.32	418.32	415.82	413.91	413.91	413.91
Additional Paid-In Capital	4,771	4,771	4,762	4,592	4,680	4,657
Retained Earnings	3,257	3,266	3,882	4,826	5,147	4,488
Treasury Stock	-52.4	-57.61	-99.92	-115.32	-336.75	-87.95
Comprehensive Income & Other	33.36	96.31	175.21	143.11	172	-152.57
Total Common Equity	8,427	8,494	9,135	9,859	10,076	9,318
Minority Interest	111.66	113.49	136.75	144.78	145.09	122.87
Shareholders' Equity	8,539	8,608	9,272	10,004	10,221	9,441
Total Liabilities & Equity	11,345	11,749	12,542	13,613	14,385	14,254
Total Debt	603.48	636.85	471.27	365.4	200.01	847.75
Net Cash (Debt)	2,761	3,141	3,838	5,144	6,203	7,798
Net Cash Growth	-15.34%	-18.17%	-25.38%	-17.07%	-20.46%	89.68%
Net Cash Per Share	6.62	7.54	9.31	12.47	15.12	18.94
Filing Date Shares Outstanding	415.74	417.02	412.38	379.44	409.91	409.91
Total Common Shares Outstanding	415.74	417.02	412.38	379.44	409.91	409.91
Working Capital	3,574	3,613	4,034	4,636	5,819	7,651
Book Value Per Share	20.27	20.37	22.15	25.98	24.58	22.73
Tangible Book Value	7,978	8,051	8,739	9,393	9,618	9,026
Tangible Book Value Per Share	19.19	19.31	21.19	24.76	23.46	22.02
Buildings	-	1,923	1,782	1,787	490.05	418.81
Machinery	-	2,509	2,362	2,195	1,841	1,612
Construction In Progress	-	10.73	205.67	418.08	752.33	38.5

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.